3 Quantum Computing Stocks to Buy Before They Soar in 2027

The quantum-computing market is projected to grow at a 33% CAGR from 2026 to 2034, and the article argues IonQ, D-Wave Quantum, and Quantum Computing could benefit as the sector expands. Their projected 2026 sales multiples are 31x, 103x, and 56x, respectively; all three are expected to remain unprofitable for the foreseeable future. The article attributes their recent pullback partly to the Iran war, inflation, and higher interest rates, while presenting the stocks as speculative buys if those headwinds ease.

Analysis

The investable question is not whether quantum computing grows, but whether any one architecture captures repeatable commercial economics before incumbents bundle access through cloud platforms. IonQ’s trapped-ion approach, D-Wave’s annealing niche, and Quantum Computing Inc.’s photonics are not interchangeable bets: D-Wave may monetize constrained optimization sooner, while IonQ’s broader use case depends on independently demonstrated performance and customer conversion. Photonic-fab scalability is a thesis, not proof of competitive cost or yield. IBM and Alphabet can use existing research budgets, cloud distribution, and customer relationships to pressure standalone vendors even if their systems remain imperfect.

The cited sales multiples embed execution years ahead; the market-growth forecast does not establish issuer-level share gains. QUBT’s unusually large 2026 growth estimate is especially vulnerable to a small-base effect and should not be treated as evidence of durable scale. For all three, unprofitability makes valuations sensitive to Treasury yields and financing/dilution risk, while any technical milestone can produce sharp countertrend rallies.

Near term (days to weeks), sentiment and rates likely dominate fundamentals. Over 1–3 months, verify reported bookings converting to recognized revenue, repeat commercial demand, gross-margin direction, cash runway, and share issuance. Over 6–18 months, the thesis requires customer workloads with measurable advantage over classical alternatives—not just system launches or market-size forecasts. No compelling directional trade follows from this article alone.

Key Decisions for Investors

• Do not buy IONQ, QBTS, or QUBT as a basket on the market-CAGR narrative; keep exposure on a watchlist pending company-reported conversion of contracts into recurring revenue and improving unit economics.
• If seeking quantum exposure now, prefer diversified IBM or Alphabet exposure over treating either as a pure-play quantum proxy; their broader businesses reduce single-technology and funding risk, though quantum may remain immaterial to near-term earnings.
• Set a 1–3 month alert for each company’s filings and earnings: track cash burn/runway, dilution, backlog-to-revenue conversion, repeat customers, and gross margin. Reassess only if commercial evidence improves without a material increase in share count.
• Falsify the standalone-growth thesis if guidance or bookings weaken, revenue growth is driven by one-off deliveries rather than repeat use, financing needs force substantial dilution, or independent benchmarks fail to show customer-relevant advantage over classical computing.